<!doctype html><html class=no-js lang=en><head><meta charset=UTF-8><meta name=viewport content="width=device-width,initial-scale=1"><title>ç§‘ç ”æ—¥æŠ¥ 2025-11-12 - ç”Ÿä¿¡æ™®æ‹‰æ–¯</title>
<script>(function(e,t){e[t]=e[t].replace("no-js","js")})(document.documentElement,"className")</script><meta name=description content><meta property="og:url" content="https://ixxmu.github.io/posts/dailyreports/2025-11-12/"><meta property="og:site_name" content="ç”Ÿä¿¡æ™®æ‹‰æ–¯"><meta property="og:title" content="ç§‘ç ”æ—¥æŠ¥ 2025-11-12"><meta property="og:description" content="ğŸ“… Daily Report - 2025-11-12 ä»Šæ—¥ç­›é€‰å‡º 91 æ¡å†…å®¹ï¼Œæ¥è‡ª 5 ä¸ªæ¥æº"><meta property="og:locale" content="zh_cn"><meta property="og:type" content="article"><meta property="article:section" content="posts"><meta property="article:published_time" content="2025-11-12T00:00:00+00:00"><meta property="article:modified_time" content="2025-11-12T00:00:00+00:00"><meta property="article:tag" content="Research"><meta property="article:tag" content="Daily"><meta property="article:tag" content="Week462025"><meta itemprop=name content="ç§‘ç ”æ—¥æŠ¥ 2025-11-12"><meta itemprop=description content="ğŸ“… Daily Report - 2025-11-12 ä»Šæ—¥ç­›é€‰å‡º 91 æ¡å†…å®¹ï¼Œæ¥è‡ª 5 ä¸ªæ¥æº"><meta itemprop=datePublished content="2025-11-12T00:00:00+00:00"><meta itemprop=dateModified content="2025-11-12T00:00:00+00:00"><meta itemprop=wordCount content="3387"><meta itemprop=keywords content="Research,Daily,Week462025"><meta name=twitter:card content="summary"><meta name=twitter:title content="ç§‘ç ”æ—¥æŠ¥ 2025-11-12"><meta name=twitter:description content="ğŸ“… Daily Report - 2025-11-12 ä»Šæ—¥ç­›é€‰å‡º 91 æ¡å†…å®¹ï¼Œæ¥è‡ª 5 ä¸ªæ¥æº"><link rel=preconnect href=https://fonts.gstatic.com crossorigin><link rel=dns-prefetch href=//fonts.googleapis.com><link rel=dns-prefetch href=//fonts.gstatic.com><link rel=stylesheet href="https://fonts.googleapis.com/css?family=Open+Sans:400,400i,700"><link rel=stylesheet href=../../../css/style.css><link rel=stylesheet href=../../../css/custom.css><link rel="shortcut icon" href=../../../favicon.ico></head><body class=body><div class="container container--outer"><header class=header><div class="container header__container"><div class=logo><a class=logo__link href=../../../ title=ç”Ÿä¿¡æ™®æ‹‰æ–¯ rel=home><div class="logo__item logo__text"><div class=logo__title>ç”Ÿä¿¡æ™®æ‹‰æ–¯</div><div class=logo__tagline>è¿‘åå¹´æœ€å€¼å¾—ä¸Šæ‰‹çš„ç”Ÿç‰©åŒ»å­¦ç”Ÿä¿¡ä»£ç </div></div></a></div><nav class=menu><button class=menu__btn aria-haspopup=true aria-expanded=false tabindex=0>
<span class=menu__btn-title tabindex=-1>Menu</span></button><ul class=menu__list><li class=menu__item><a class=menu__link href=../../../posts/><span class=menu__text>æ–‡ç« </span></a></li><li class=menu__item><a class=menu__link href=../../../tags/><span class=menu__text>æ ‡ç­¾</span></a></li><li class=menu__item><a class=menu__link href=../../../about/><span class=menu__text>å…³äº</span></a></li></ul></nav></div></header><div class="wrapper flex"><div class=primary><main class=main role=main><article class=post><header class=post__header><meta name=referrer content="never"><h1 class=post__title>ç§‘ç ”æ—¥æŠ¥ 2025-11-12</h1><div class="post__meta meta"><div class="meta__item-datetime meta__item"><svg class="meta__icon icon icon-time" width="16" height="14" viewBox="0 0 30 28"><path d="M15 0a14 14 0 110 28 1 1 0 010-28m0 3a3 3 0 100 22 3 3 0 000-22m1 4h-2v8.4l6.8 4.4L22 18l-6-3.8z"/></svg><time class=meta__text datetime=2025-11-12T00:00:00Z>2025-11-12</time></div><div class="meta__item-categories meta__item"><svg class="meta__icon icon icon-category" width="16" height="16" viewBox="0 0 16 16"><path d="m7 2 1 2h8v11H0V2z"/></svg><span class=meta__text><a class=meta__link href=../../../categories/dailyreport/ rel=category>DailyReport</a></span></div><div class="meta__item-author meta__item"><svg class="meta__icon icon icon-author" width="16" height="16" viewBox="0 0 16 16"><path d="M8 1c2 0 3.5 2 3.5 4.5S10 9 10 9c3 1 4 2 4 6H2c0-4 1-5 4-6 0 0-1.5-1-1.5-3.5S6 1 8 1"/></svg><span class=meta__text>Bloger</span></div></div></header><div class="post__toc toc"><div class=toc__title>Page content</div><div class=toc__menu><nav id=TableOfContents><ul><li><a href=#-ä»Šæ—¥aiæ™ºèƒ½æ€»ç»“>ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“</a><ul><li><a href=#-å…¬ä¼—å·>ğŸ“° å…¬ä¼—å·</a></li><li><a href=#-æ•°æ®å‰æ²¿>ğŸ§¬ æ•°æ®å‰æ²¿</a></li><li><a href=#-æœŸåˆŠæ–‡ç« >ğŸ”¬ æœŸåˆŠæ–‡ç« </a></li><li><a href=#-å­¦ç‚¹ç”Ÿä¿¡>ğŸ“Š å­¦ç‚¹ç”Ÿä¿¡</a></li><li><a href=#-åšå®¢æ›´æ–°>ğŸ§ª åšå®¢æ›´æ–°</a></li></ul></li><li><a href=#-åˆ†ç±»æµè§ˆ>ğŸ“š åˆ†ç±»æµè§ˆ</a><ul><li></li></ul></li><li><a href=#-å…³é”®è¯ç»Ÿè®¡>ğŸ“Š å…³é”®è¯ç»Ÿè®¡</a></li><li><a href=#-æ›´å¤šå†…å®¹>ğŸ“ æ›´å¤šå†…å®¹</a></li></ul></nav></div></div><div class="content post__content clearfix"><h1 id=-daily-report---2025-11-12>ğŸ“… Daily Report - 2025-11-12</h1><blockquote><p>ä»Šæ—¥ç­›é€‰å‡º <strong>91</strong> æ¡å†…å®¹ï¼Œæ¥è‡ª <strong>5</strong> ä¸ªæ¥æº</p></blockquote><div class=powered-by-top>Powered by <a href=https://kyplus.de>ç§‘ç ”æ™®æ‹‰æ–¯</a> & <a href=https://claude.ai>Claude</a></div><hr><h2 id=-ä»Šæ—¥aiæ™ºèƒ½æ€»ç»“>ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“</h2><h3 id=-å…¬ä¼—å·>ğŸ“° å…¬ä¼—å·</h3><blockquote><p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š
QIAGEN 2.25äº¿ç¾å…ƒæŠ•èµ„AIé©±åŠ¨å•ç»†èƒç ”ç©¶ï¼Œå¹¶æ¨å‡ºé¦–ä¸ªèåˆç©ºé—´ç»„å­¦ä¸å•ç»†èƒç»„å­¦çš„æ·±åº¦åŸºç¡€æ¨¡å‹ã€‚</p></blockquote><p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š</p><ul><li>è‚¿ç˜¤å¾®ç¯å¢ƒä¸é¢„åç”Ÿç‰©å­¦äºšå‹åˆ†æï¼ˆå¦‚Mantle cell lymphomaï¼‰</li><li>è‚ºéƒ¨ç–¾ç—…ï¼ˆå¦‚æ–°å† è‚ºæŸä¼¤ï¼‰çš„çº¤ç»´åŒ–æœºåˆ¶åŠä¿¡å·é€šè·¯ç ”ç©¶</li><li>è‚ç»†èƒç™Œèµ·æºä¸ä»£è°¢åˆ†åŒºå…³ç³»</li></ul><p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š</p><ul><li>ç©ºé—´ç»„å­¦ä¸å•ç»†èƒç»„å­¦çš„æ·±åº¦èåˆåˆ†æ</li><li>å¤šç»„å­¦ï¼ˆåŸºå› ç»„ã€å•ç»†èƒã€ç©ºè½¬ã€ä»£è°¢ç­‰ï¼‰è”åˆåˆ†æä¸æœºå™¨å­¦ä¹ åº”ç”¨</li><li>åˆ©ç”¨ç±»å™¨å®˜æ¨¡å‹å®ç°ä½“å†…ç»†èƒè¯±å¯¼é‡ç¼–ç¨‹</li></ul><h3 id=-æ•°æ®å‰æ²¿>ğŸ§¬ æ•°æ®å‰æ²¿</h3><blockquote><p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š
3DæŸ“è‰²è´¨å›¾è°±æ­ç¤ºè‡ªèº«å…ç–«ç—…æ˜“æ„Ÿæ€§èƒŒåçš„ç»†èƒåŠé—ä¼ æœºåˆ¶ï¼›æ–°å‹å•ç»†èƒæµ‹åºæŠ€æœ¯æ•´åˆå¤šç»„å­¦æ•°æ®ï¼Œé‡æ„è¡¨è§‚é—ä¼ åŠ¨æ€ã€‚</p></blockquote><p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š</p><ul><li><strong>ç–¾ç—…æœºåˆ¶ç ”ç©¶</strong>ï¼šåˆ©ç”¨å•ç»†èƒæµ‹åºæŠ€æœ¯å‰–æé’å…‰çœ¼æ¨¡å‹ä¸­çš„çº¿ç²’ä½“åŠŸèƒ½éšœç¢ã€è‚¿ç˜¤å…ç–«å¯¹æ”¾åŒ–ç–—è”åˆå…ç–«æ£€æŸ¥ç‚¹é˜»æ–­çš„å“åº”æœºåˆ¶ï¼Œä»¥åŠè‚ºéƒ¨æŸä¼¤ä¸­çš„å…ç–«è°ƒæ§ã€‚</li><li><strong>ç™Œç—‡å‘ç”Ÿä¸æ²»ç–—</strong>ï¼šç ”ç©¶è‚ç™Œèµ·æºçš„ä»£è°¢åŒºå¸¦è°ƒæ§ï¼Œä»¥åŠåŒ–å­¦æ”¾ç–—å¯¹å®«é¢ˆç™Œè‚¿ç˜¤ç»†èƒå’Œå…ç–«å¾®ç¯å¢ƒçš„é‡å¡‘ï¼Œæ¢ç´¢MSLNæ•²ä½æé«˜åµå·¢ç™ŒæŠ—PD-1ç–—æ•ˆã€‚</li><li><strong>è¡°è€ä¸ç–¾ç—…</strong>ï¼šè§£æTKIç±»è¯ç‰©å¿ƒè„æ¯’æ€§çš„å¤šå°ºåº¦ç‰¹å¾åŠPIEZO1çš„ä¿æŠ¤ä½œç”¨ï¼Œç ”ç©¶æ ¸å¤åˆç‰©åœ¨ä¸‰é˜´æ€§ä¹³è…ºç™Œç»†èƒè¡°è€ä¸­çš„è°ƒæ§ã€‚</li></ul><p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š</p><ul><li>æ•´åˆå¤šç§é«˜é€šé‡æµ‹åºæŠ€æœ¯ï¼ˆRNA-seq, ATAC-seq, Hi-C, ChIP-seq, snMultiomeï¼‰è¿›è¡Œå¤šç»´åº¦ç”Ÿç‰©å­¦è§£æã€‚</li><li>å¼€å‘å•ç»†èƒå¤šè¡¨è§‚é—ä¼ æ•°æ®æ•´åˆæ¡†æ¶ï¼Œå®ç°è¡¨è§‚é—ä¼ åŠ¨æ€çš„ç²¾ç»†é‡æ„ã€‚</li></ul><h3 id=-æœŸåˆŠæ–‡ç« >ğŸ”¬ æœŸåˆŠæ–‡ç« </h3><blockquote><p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š
æ­ç¤ºä¸åŒç±»å‹ç³–å°¿ç—…ä¸èƒ°è…ºç™Œé£é™©çš„é—ä¼ å…³è”ï¼›å‘ç°æ›²å¦¥ç å•æŠ—Deruxtecanè€è¯æœºåˆ¶ä¸HER2è¡¨è¾¾ä¸§å¤±ç›¸å…³ã€‚</p></blockquote><p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š</p><ul><li><strong>ç³–å°¿ç—…ä¸èƒ°è…ºç™Œçš„é—ä¼ å…³è”ç ”ç©¶</strong>ï¼šåˆ©ç”¨å­Ÿå¾·å°”éšæœºåŒ–åˆ†æ2å‹ã€1å‹ç³–å°¿ç—…åŠMODYä¸èƒ°è…ºå¯¼ç®¡è…ºç™Œï¼ˆPDACï¼‰çš„é£é™©ã€‚</li><li><strong>è‚¿ç˜¤è¯ç‰©å¼€å‘ä¼˜åŒ–</strong>ï¼šç³»ç»Ÿè¯„ä»·éª¨é«“ç˜¤éšæœºå¯¹ç…§è¯•éªŒï¼Œè¯†åˆ«æé«˜è¯ç‰©ç ”å‘æˆåŠŸç‡çš„å…³é”®å› ç´ ã€‚</li><li><strong>ä¹³è…ºç™Œé¶å‘æ²»ç–—è€è¯æœºåˆ¶</strong>ï¼šé˜æ˜æ›²å¦¥ç å•æŠ—Deruxtecanï¼ˆT-DXdï¼‰æ²»ç–—ä¸­HER2è¡¨è¾¾ä¸‹é™å’Œä¸§å¤±æ˜¯äº§ç”Ÿè€è¯æ€§çš„ä¸»è¦åŸå› ã€‚</li><li><strong>å¤´é¢ˆéƒ¨é³çŠ¶ç»†èƒç™Œæ–°è¾…åŠ©å…ç–«æ²»ç–—</strong>ï¼šç»¼è¿°å½“å‰è¿›å±•ï¼Œå¹¶æå‡ºé€šè¿‡è°ƒæ§å…ç–«å¾®ç¯å¢ƒä»¥æé«˜ç–—æ•ˆçš„ç­–ç•¥ã€‚</li><li><strong>å†œæ‘ç™Œç—‡å·®å¼‚çš„å®šä¹‰ä¸ç ”ç©¶</strong>ï¼šå€¡å¯¼é‡‡ç”¨åŸºäºèº«ä»½å’Œç¤¾åŒºå‚ä¸çš„æ–¹æ³•ï¼Œå…‹æœç°æœ‰åŸä¹¡åˆ†ç±»çš„å±€é™æ€§ï¼Œæ›´å‡†ç¡®åœ°ç†è§£å†œæ‘ç™Œç—‡å·®å¼‚ã€‚</li></ul><p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š</p><ul><li><strong>å­Ÿå¾·å°”éšæœºåŒ–åˆ†æ</strong>ï¼šç”¨äºæ¢ç´¢ç³–å°¿ç—…ç±»å‹ä¸èƒ°è…ºç™Œé£é™©ä¹‹é—´çš„å› æœå…³ç³»ã€‚</li><li><strong>åˆ†å­è¡¨å¾ä¸åŒåŸºå› æ¨¡å‹</strong>ï¼šç»“åˆæ‚£è€…æ ·æœ¬åˆ†æå’Œä½“å¤–æ¨¡å‹ï¼Œè§£æT-DXdçš„è€è¯æœºåˆ¶ã€‚</li></ul><h3 id=-å­¦ç‚¹ç”Ÿä¿¡>ğŸ“Š å­¦ç‚¹ç”Ÿä¿¡</h3><blockquote><p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š
æ¢ç´¢åœ†å‘¨ç‡ï¼ˆPiï¼‰ä¸­éšè—çš„æ— é™å¯èƒ½æ€§ï¼Œé€šè¿‡Rè¯­è¨€å‡½æ•°å¼€å‘ï¼Œä¸ºå­—ç¬¦ä¸²æœç´¢æä¾›æ–°æ€è·¯ã€‚</p></blockquote><p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š</p><ul><li>åŸºäºRè¯­è¨€ï¼Œå¼€å‘ç”¨äºåœ¨åœ†å‘¨ç‡æ— é™åºåˆ—ä¸­æœç´¢ç‰¹å®šæ•°å­—ä¸²çš„å·¥å…·ã€‚</li><li>éªŒè¯åœ†å‘¨ç‡æ˜¯å¦åŒ…å«æ‰€æœ‰å¯èƒ½çš„æ•°å­—ç»„åˆï¼Œå¹¶æ¢è®¨å…¶å®é™…åº”ç”¨æ½œåŠ›ã€‚</li></ul><p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š</p><ul><li><strong>æ–°å‹Rå‡½æ•°åº”ç”¨</strong>ï¼šåˆ›é€ æ€§åœ°åˆ©ç”¨Rè¯­è¨€å‡½æ•°å¤„ç†å’Œæœç´¢åœ†å‘¨ç‡çš„æ— é™åºåˆ—ã€‚</li><li><strong>æ•°æ®æŒ–æ˜æ–¹æ³•</strong>ï¼šæ¢ç´¢åœ¨æµ·é‡æ•°å­—æ•°æ®ä¸­å®šä½ç‰¹å®šæ¨¡å¼çš„ç®—æ³•ã€‚</li></ul><h3 id=-åšå®¢æ›´æ–°>ğŸ§ª åšå®¢æ›´æ–°</h3><blockquote><p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š
RNAæµ‹åºæŠ€æœ¯åœ¨æ­ç¤ºç”Ÿç‰©å­¦å·®å¼‚å’Œç–¾ç—…æœºåˆ¶æ–¹é¢å–å¾—çªç ´ã€‚</p></blockquote><p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š</p><ul><li>æ¢ç©¶å¹´é¾„ã€æ€§åˆ«ç­‰åå˜é‡å¯¹RNAå‰ªæ¥å˜åŒ–çš„å½±å“ã€‚</li><li>é˜æ˜å¥³æ€§é•¿æ–°å† ï¼ˆLong COVIDï¼‰ç—‡çŠ¶æ›´ä¸¥é‡çš„åŸå› ï¼Œæ¶‰åŠå…ç–«ã€æ¿€ç´ å’Œä»£è°¢å·®å¼‚ã€‚</li></ul><p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š</p><ul><li>å¼€å‘äº†MntJULiPå’ŒJutilså·¥å…·ï¼Œç”¨äºç²¾ç¡®åˆ†æRNAæµ‹åºæ•°æ®ä¸­å—åå˜é‡å½±å“çš„RNAå‰ªæ¥å˜åŒ–ã€‚</li></ul><hr><h2 id=-åˆ†ç±»æµè§ˆ>ğŸ“š åˆ†ç±»æµè§ˆ</h2><details><summary style="text-align:right;direction:rtl;padding:10px 15px;background:linear-gradient(135deg,#f8f9fa 0%,#e9ecef 100%);border-right:4px solid #667eea;font-weight:600;cursor:pointer;margin:15px 0;border-radius:6px">ğŸ“° å…¬ä¼—å· (17æ¡)</summary><div class=details-content markdown=1><h4 id=è¯¦ç»†å†…å®¹å‰10æ¡>è¯¦ç»†å†…å®¹ï¼ˆå‰10æ¡ï¼‰</h4><p><strong>1.</strong> â­ <strong>QIAGENè±ªæ·2.25äº¿ç¾å…ƒå¼€å¯å•ç»†èƒAIé©±åŠ¨æ–°æ—¶ä»£ï¼›é¦–ä¸ªå°†ç©ºé—´ç»„å­¦ä¸å•ç»†èƒç»„å­¦æ·±åº¦èåˆçš„åŸºç¡€æ¨¡å‹ï¼›è‚¾ç™Œå…ç–«ç–—æ³•è€è¯æ–°æœºåˆ¶ç­‰</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šå•ç»†èƒå¤©åœ°</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šå…ç–«ã€è€è¯ã€å•ç»†èƒã€ç©ºé—´ç»„å­¦</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzI1Njk4ODE0MQ==&amp;mid=2247533611&amp;idx=1&amp;sn=f53e163cc8b279c6234644ed113667f0">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>2.</strong> â­ <strong>åŸºå› ç»„+ç©ºé—´ç»„&ndash;åŠŸèƒ½åŸºå› ç»„å­¦ä¸è‚¿ç˜¤å¾®ç¯å¢ƒåˆ†ææ­ç¤ºMantle cell lymphomaçš„é¢„åç”Ÿç‰©å­¦äºšå‹</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šå•ç»†èƒç©ºé—´äº¤å“ä¹</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤ã€lymphomaã€ç©ºé—´ç»„å­¦ã€åŸºå› ç»„</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šåŸºå› ç»„+ç©ºé—´ç»„&ndash;åŠŸèƒ½åŸºå› ç»„å­¦ä¸è‚¿ç˜¤å¾®ç¯å¢ƒåˆ†ææ­ç¤ºMantle cell lymphomaçš„é¢„åç”Ÿç‰©å­¦äºšå‹</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg2MDY1NTYyOQ==&amp;mid=2247498859&amp;idx=1&amp;sn=62df1cebc4d6545cbe416742993efc88">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>3.</strong> â­ <strong>ç©ºé—´è½¬å½•ç»„+å•ç»†èƒè”åˆåˆ†æï¼Œè¿™ç¯‡æ–°å† è‚ºæŸä¼¤ç ”ç©¶æ­ç¤ºSPP1ä¿¡å·ä¿ƒè¿›çº¤æº¶å…³é—­ï¼Œåˆ†ææµç¨‹å¯ç›´æ¥å¥—ç”¨å…¶ä»–çº¤ç»´åŒ–ç–¾ç—…ï¼</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡å°åšå£«</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šå•ç»†èƒã€ç©ºé—´è½¬å½•ç»„ã€è½¬å½•ç»„</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg2NDcxMzYwNg==&amp;mid=2247490515&amp;idx=1&amp;sn=3d28bd2eaa98cee6267b0dcfc43cd49e">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>4.</strong> â­ <strong>æœ€æ–°8.5åˆ†å•åŸºå› ç”Ÿä¿¡ï¼Œæ³›ç™Œ+å•ç»†èƒ+ç©ºè½¬+éªŒè¯ï¼Œå¤šç»„å­¦åˆ†æä¸€èµ·ä¸Šåˆ†ï¼</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡å°è¯¾å ‚</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šå•ç»†èƒã€åŸºå› ç»„ã€ç”Ÿä¿¡</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šç‚¹å‡»æŸ¥çœ‹è¯¦æƒ…</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&amp;mid=2247503930&amp;idx=2&amp;sn=ebe229227a93f9635bf12b876a4a8475">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>5.</strong> <strong>å•ç»†èƒè½¬å½•ç»„å­¦åˆ†ææ­ç¤ºé£Ÿç®¡å°ç»†èƒç™Œçš„ä¸Šçš®å’Œå¾®ç¯å¢ƒå¼‚è´¨æ€§</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡èœé¸Ÿå›¢</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šå•ç»†èƒã€è½¬å½•ç»„</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzUzMTEwODk0Ng==&amp;mid=2247537963&amp;idx=1&amp;sn=f397b62fcee5ade8c48023df4cb63cac">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>6.</strong> <strong>æœ€æ–°7.5åˆ†ç”Ÿä¿¡ï¼Œå¤šç»„å­¦ç»“åˆæœºå™¨å­¦ä¹ ç­›é€‰è‚¥èƒ–ç›¸å…³çš„å…³é”®åŸºå› å¹¶éªŒè¯ï¼Œéè‚¿ç˜¤ç»å…¸æ€è·¯ï¼</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šç”Ÿä¿¡å°è¯¾å ‚</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤ã€ç”Ÿä¿¡</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šç‚¹å‡»æŸ¥çœ‹è¯¦æƒ…</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&amp;mid=2247503930&amp;idx=1&amp;sn=fc668c98b03e36dbe94716c050c88679">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>7.</strong> <strong>è¿™ç§å¸¸è§ç»´ç”Ÿç´ ï¼Œç«Ÿä¸ä¿ƒè¿›ç™Œç—‡ç”Ÿé•¿æœ‰å…³ï¼ç ”ç©¶å‘ç°ï¼šå‡å°‘æ‘„å…¥å³å¯é˜»æ­¢å°é¼ è‚¿ç˜¤ç”Ÿé•¿</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šä¸é¦™å­¦æœ¯</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤ã€ç™Œç—‡</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šå¤šé¡¹ç ”ç©¶å†æ·»æ–°è¯ï¼</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzUxMzk5MjY5NA==&amp;mid=2247649831&amp;idx=1&amp;sn=ff35bf3dfb08116d6ecc25ae99363175">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>8.</strong> <strong>ä»£è°¢é…¶çš„â€œéç»å…¸â€æœºåˆ¶â€”è¡¨è§‚é‡ç¼–ç¨‹ï¼Œçœ‹æ‡‚è¿™ç¯‡Cell Metabolismè¿˜ç¼ºå‘é¡¶åˆŠçš„æ€è·¯å—ï¼Ÿ</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šå°å¼ èŠç§‘ç ”</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šä»£è°¢ã€metabolism</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šè¯¾é¢˜å’Œæ–‡ç« æ€è·¯è¯·è”ç³»Alice@è§£é¢ç”Ÿç‰©,æ‰«ç å¤‡æ³¨ï¼šç§‘ç ”æœåŠ¡</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzAwMzY4MTYxNw==&amp;mid=2655821349&amp;idx=4&amp;sn=2e0db14abef1602510e139f90fe67668">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>9.</strong> <strong>BD Rhapsodyå•ç»†èƒåŸºå› è¡¨è¾¾å®šé‡</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šseqyuan</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šå•ç»†èƒ</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šBD Rhapsodyä¸Šæ¸¸åˆ†æï¼Œå•ç»†èƒåŸºå› è¡¨è¾¾å®šé‡</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzU1MDMyNzUyNQ==&amp;mid=2247484726&amp;idx=1&amp;sn=a0cfd119672edfdc4afc206e3fea9711">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>10.</strong> <strong>è¯¦è§£ï¼šäººä½“æ¶ˆåŒ–ç³»ç»Ÿçš„ç‰©è´¨ä»£è°¢è¿‡ç¨‹</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šå°æä»£è°¢</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šä»£è°¢</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šäººä½“æ¶ˆåŒ–ç³»ç»Ÿæ˜¯ä¸€ä¸ªå¤æ‚è€Œé«˜æ•ˆçš„ä½“ç³»ï¼Œé€šè¿‡æœºæ¢°å’ŒåŒ–å­¦çš„ååŒä½œç”¨ï¼Œå°†é£Ÿç‰©åˆ†è§£ä¸ºå¯å¸æ”¶çš„å°åˆ†å­ã€‚</li><li>ğŸ”— <a href="https://mp.weixin.qq.com/s?__biz=MzYyNDMwNjg3Nw==&amp;mid=2247484022&amp;idx=1&amp;sn=01686237c49693d570039970b6b2b1d7">æŸ¥çœ‹åŸæ–‡</a></li></ul><blockquote><p>ğŸ’¡ è¯¥æ¥æºè¿˜æœ‰ 7 æ¡å†…å®¹ï¼Œè¯¦è§ <a href=#%E6%9B%B4%E5%A4%9A-%E5%85%AC%E4%BC%97%E5%8F%B7>æ–‡æœ«</a></p></blockquote></div></details><details><summary style="text-align:right;direction:rtl;padding:10px 15px;background:linear-gradient(135deg,#f8f9fa 0%,#e9ecef 100%);border-right:4px solid #667eea;font-weight:600;cursor:pointer;margin:15px 0;border-radius:6px">ğŸ§¬ æ•°æ®å‰æ²¿ (66æ¡)</summary><div class=details-content markdown=1><h4 id=è¯¦ç»†å†…å®¹å‰10æ¡-1>è¯¦ç»†å†…å®¹ï¼ˆå‰10æ¡ï¼‰</h4><p><strong>1.</strong> â­ <strong>GSE309500ï¼šå¯¹å°æ¢ç½‘è¿›è¡Œå•ç»†èƒåˆ†æï¼Œå‘ç°é’å…‰çœ¼æ¨¡å‹ä¸­å­˜åœ¨çº¿ç²’ä½“åŠŸèƒ½éšœç¢ï¼Œè€Œç»´ç”Ÿç´ B3æ²»ç–—å¯ä¿æŠ¤è¯¥åŠŸèƒ½ã€‚</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€oncologyã€carcinomaã€leukemiaã€immuneã€immunityã€TMEã€cardiacã€gliomaã€kinaseã€resistanceã€TCGAã€single.cellã€single-cellã€scRNAã€scDNAã€scATACã€spatialã€spatiallyã€genomeã€genomicsã€proteomeã€proteomicsã€Bioconductorã€Seuratã€Scanpyã€epigeneticã€epigenomeã€methylationã€histoneã€enrichmentã€clustering</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Revathi Balasubramanian ; Taibo Li ; Guorong LiSeries Type : Genome binding/occupancy profiling by high throughput sequencing ; Expression profiling by high throughput sequencingOrganism : Mus musculusSince the trabecular meshwork (TM) is central to intraocular pressure (IOP) regulation and glaucoma, a deeper understanding of its genomic landscape is needed. We present a multimodal, single-cell resolution analysis of mouse limbal cells (includes TM). In total, we sequenced 9,394 wild-type TM cell transcriptomes. We discovered three TM cell subtypes with characteristic signature genes validated by immunofluorescence on tissue sections and whole-mounts. The subtypes are robust, being detected in datasets for two diverse mouse strains and in independent data from two institutions. Results show compartmentalized enrichment of critical pathways in specific TM cell subtypes. Distinctive signatures include increased expression of genes responsible for 1) extracellular matrix structure and metabolism (TM1 subtype), 2) secreted ligand signaling to support Schlemmâ€™s canal cells (TM2), and 3) contractile and mitochondrial/metabolic activity (TM3). ATAC-sequencing data identified active transcription factors in TM cells, including LMX1B. Mutations in LMX1B cause high IOP and glaucoma. LMX1B is emerging as a key transcription factor for normal mitochondrial function and its expression is much higher in TM3 cells than other limbal cells. To understand the role of LMX1B in TM function and glaucoma, we single-cell sequenced limbal cells from Lmx1bV265D/+ mutant mice (2,491 TM cells). In V265D/+ mice, TM3 cells were uniquely affected by pronounced mitochondrial pathway changes. Mitochondria in TM cells of V265D/+ mice are swollen with a reduced cristae area, further supporting a role for mitochondrial dysfunction in the initiation of IOP elevation in these mice. Importantly, treatment with vitamin B3 (nicotinamide), to enhance mitochondrial function and metabolic resilience, significantly protected Lmx1b mutant mice from IOP elevation.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309500">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>2.</strong> â­ <strong>GSE275609 æ”¾å°„æ€§è¯ç‰©+æ£€æŸ¥ç‚¹é˜»æ–­æ²»ç–—åçš„è‚¿ç˜¤å…ç–«åŠ›éšæ²»ç–—é¡ºåºã€æ”¾å°„æ€§åŒä½ç´ å’Œè‚¿ç˜¤å…ç–«åŸæ€§è€Œå˜åŒ–</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€oncologyã€leukemiaã€immuneã€immunityã€immunologyã€TMEã€cardiacã€gliomaã€kinaseã€DepMapã€depmapã€sequencingã€RNAseqã€scRNAã€scDNAã€scATACã€spatialã€spatiallyã€Visiumã€genomeã€genomicsã€transcriptomeã€proteomeã€R packageã€Seuratã€Scanpyã€histoneã€pathwayã€enrichmentã€clustering</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šSeries Type : Expression profiling by high throughput sequencing ; OtherOrganism : Mus musculusRadiopharmaceutical therapy (RPT) enhances tumor response to immune checkpoint inhibitors (ICI) in preclinical models, but the effects of different radioisotopes have not been compared. To evaluate mechanisms of response to RPT+ICI, we used NM600, an alkylphosphocholine selectively taken up by most tumors. Effects of 90Y-, 177Lu-, and 225Ac-NM600 + ICIs were compared in syngeneic murine models, B78 melanoma (poorly immunogenic) and MC38 colorectal cancer (immunogenic). 90Y-/177Lu-/or 225Ac-NM600 delivering 2 Gy mean tumor dose promoted tumor regression and improved survival when combined with ICIs in syngeneic mice bearing B78 or MC38 tumors. Regardless of the administered isotope, this combination was optimized with early ICI administration (days -3/0/3) relative to day 1 RPT. 90Y-NM600+ICI produced the greatest anti-tumor response for MC38, whereas high linear energy transfer (LET) alpha particle radiation from 225Ac-NM600+ICI was most effective against poorly immunogenic B78 tumors. Flow cytometry and single cell RNA and T cell receptor (TCR) sequencing illuminated distinct mechanisms of 90Y- or 177Lu-NM600 in promoting expansion of existing adaptive immunity and of 225Ac-NM600 in promoting immune priming when combined with ICI. Antitumor immune response can be achieved with appropriate application of Î±- or Î²- emitting RPT in combination with ICIs in diverse murine tumor models.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE275609">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>3.</strong> â­ <strong>GSE220699 åŸºäºå•ç»†èƒRNAæµ‹åºæŠ€æœ¯ç­›é€‰ç‰¹å®šç”Ÿç‰©æ ‡å¿—ç‰©å¹¶ç ”ç©¶å¸å…¥æ€§æŸä¼¤ï¼ˆILIï¼‰å’Œåˆ›ä¼¤æ€§è‚ºæŸä¼¤ï¼ˆTLIï¼‰çš„å…ç–«è°ƒèŠ‚æœºåˆ¶</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€oncologyã€carcinomaã€immuneã€immunityã€immunologyã€TMEã€metabolicã€cardiacã€gliomaã€kinaseã€resistanceã€TCGAã€sequencingã€RNAseqã€single.cellã€scRNAã€scDNAã€scATACã€spatialã€spatiallyã€genomeã€genomicsã€bioinformaticsã€Bioconductorã€Seuratã€epigeneticã€epigenomeã€methylationã€histoneã€enrichment</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Chenru Wei ; Zong Shen ; Guosheng Wu ; Tao Tang ; Wenjia Hou ; Banghui Zhu ; Yu SunSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensTo profile the circulating immunological traits of patients with traumatic lung injury (TLI) and inhalation injury (ILI),providing a new direction for the depth research of the pathogenesis, and providing new immune-related targets for diagnosis of the severity of lung injury and treatment, we performed scRNA-seq of neutrophil and PBMCs from fresh circulating blood from 3 patients with TLI and 3 patients with ILI at longitudinal timepoints,as well as peripheral blood from 3 health controls(HCs).We conclude that at different stages of the course of TLI or ILI, there are differences in the proportion of immune cell subsets. PMN function is disordered in the acute stage and the progressive stage, and immature neutrophil subsets of different degrees appear which indicates acute myeloid cells are generated. At the same time, the interactions among the subpopulations of myeloid cells are significantly enhanced during the acute phase, which synergistically promote the development of TLI or ILI.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE220699">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>4.</strong> â­ <strong>GSE271957 3DæŸ“è‰²è´¨å˜å¼‚åŸºå› å›¾è°±è·¨è¶Š57ç§äººç±»ç»†èƒç±»å‹æ­ç¤ºè‡ªèº«å…ç–«ç–¾ç—…æ˜“æ„Ÿæ€§çš„ç»†èƒå’Œé—ä¼ ç»“æ„[RNA-seq]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€immuneã€immunityã€TMEã€cardiacã€gliomaã€TCGAã€DepMapã€depmapã€RNA-seqã€RNAseqã€DNA-seqã€ChIP-seqã€ATAC-seqã€Hi-Cã€single.cellã€scRNAã€scDNAã€scATACã€spatialã€Visiumã€genomeã€genomicsã€proteomeã€proteomicsã€Seuratã€Scanpyã€methylationã€histoneã€enrichment</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Khanh B Trang ; Megan K Levings ; Struan F Grant ; Andrew D WellsSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensThe genetic basis for many common autoimmune disorders has been uncovered by genome-wide association studies (GWAS), but GWAS do not reveal causal variants, effector genes, or the cell types impacted by disease-associated variation. We have generated 3D genomic datasets consisting of promoter-focused Capture-C, Hi-C, ATAC-seq, and RNA-seq and integrated these data with GWAS of 16 autoimmune traits to physically map disease-associated variants to the genes they likely regulate in over 50 human cell types. These 3D maps of gene cis-regulatory architecture are highly powered to identify the cell types most likely impacted by disease-associated genetic variation compared to 1D genomic features, and tend to implicate different effector genes than eQTL approaches in the same cell types. Most of the variants implicated by these cis-regulatory architectures are highly trait-specific, but nearly half of the target genes connected to these variants are shared across multiple autoimmune disorders in multiple cell types, suggesting a high level of genetic diversity and complexity among autoimmune diseases that nonetheless converge at the level of target gene and cell type. Substantial effector gene sharing led to common enrichment of similar biological networks across disease and cell type, however, trait-specific pathways representing potential areas for disease-specific intervention were identified. To test this, we functionally validated squalene synthase, a cholesterol biosynthetic enzyme encoded by the FDFT1 gene implicated in MS and SLE, as a novel immunomodulatory drug target controlling inflammatory cytokine production by human T cells. These data represent a comprehensive resource for basic discovery of gene cis-regulatory mechanisms, and the analyses reported reveal mechanism by which autoimmune-associated variants act to regulate gene expression, function, and pathology across multiple, distinct tissues and cell types.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE271957">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>5.</strong> â­ <strong>GSE272120 3DæŸ“è‰²è´¨å˜å¼‚åŸºå› å›¾è°±è·¨è¶Š57ç§äººç±»ç»†èƒç±»å‹æ­ç¤ºè‡ªèº«å…ç–«ç–¾ç—…æ˜“æ„Ÿæ€§çš„ç»†èƒå’Œé—ä¼ ç»“æ„[ATAC-seq]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€immuneã€immunityã€TMEã€cardiacã€gliomaã€TCGAã€DepMapã€depmapã€RNA-seqã€RNAseqã€DNA-seqã€ChIP-seqã€ATAC-seqã€Hi-Cã€single.cellã€scRNAã€scDNAã€scATACã€spatialã€Visiumã€genomeã€genomicsã€proteomeã€proteomicsã€Seuratã€Scanpyã€methylationã€histoneã€enrichment</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Khanh B Trang ; Megan K Levings ; Struan F Grant ; Andrew D WellsSeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Homo sapiensThe genetic basis for many common autoimmune disorders has been uncovered by genome-wide association studies (GWAS), but GWAS do not reveal causal variants, effector genes, or the cell types impacted by disease-associated variation. We have generated 3D genomic datasets consisting of promoter-focused Capture-C, Hi-C, ATAC-seq, and RNA-seq and integrated these data with GWAS of 16 autoimmune traits to physically map disease-associated variants to the genes they likely regulate in over 50 human cell types. These 3D maps of gene cis-regulatory architecture are highly powered to identify the cell types most likely impacted by disease-associated genetic variation compared to 1D genomic features, and tend to implicate different effector genes than eQTL approaches in the same cell types. Most of the variants implicated by these cis-regulatory architectures are highly trait-specific, but nearly half of the target genes connected to these variants are shared across multiple autoimmune disorders in multiple cell types, suggesting a high level of genetic diversity and complexity among autoimmune diseases that nonetheless converge at the level of target gene and cell type. Substantial effector gene sharing led to common enrichment of similar biological networks across disease and cell type, however, trait-specific pathways representing potential areas for disease-specific intervention were identified. To test this, we functionally validated squalene synthase, a cholesterol biosynthetic enzyme encoded by the FDFT1 gene implicated in MS and SLE, as a novel immunomodulatory drug target controlling inflammatory cytokine production by human T cells. These data represent a comprehensive resource for basic discovery of gene cis-regulatory mechanisms, and the analyses reported reveal mechanism by which autoimmune-associated variants act to regulate gene expression, function, and pathology across multiple, distinct tissues and cell types.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE272120">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>6.</strong> â­ <strong>GSE309754 é…ªæ°¨é…¸æ¿€é…¶æŠ‘åˆ¶å‰‚å¿ƒè„æ¯’æ€§çš„å¤šå°ºåº¦åˆ†ææ­ç¤ºæœºæ¢°æ•æ„Ÿç¦»å­é€šé“ PIEZO1 å…·æœ‰å¿ƒè„ä¿æŠ¤ä½œç”¨ [snMultiome]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€TMEã€metabolismã€metabolicã€metabolomeã€cardiacã€gliomaã€kinaseã€resistanceã€TCGAã€single.cellã€scRNAã€scDNAã€scATACã€spatialã€Visiumã€genomeã€genomicsã€transcriptomeã€proteomeã€proteomicsã€Seuratã€epigeneticã€epigenomeã€methylationã€histone</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Nazish Sayed ; Yu LiuSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusTyrosine kinase inhibitors (TKIs) have improved cancer outcomes but are limited by cardiovascular toxicity, most notably hypertension and heart failure. The underlying mechanisms remain poorly understood, hindering the development of protective strategies. Here, we investigated the role of endothelial mechanotransduction in mediating vascular and cardiac injury caused by the VEGFR-targeting TKI sunitinib. Using patient-specific induced pluripotent stem cell-derived endothelial cells (iPSC-ECs) and a mouse model of TKI-induced hypertension, we identified downregulation of PIEZO1, a mechanically activated ion channel, as a central driver of endothelial dysfunction. Restoring PIEZO1 expression, either pharmacologically with Yoda1, a selective agonist, or through inducible overexpression in iPSC-ECs, reversed sunitinib-induced endothelial dysfunction and mitigated its hypertensive effects, providing both mechanistic and genetic validation of PIEZO1â€™s protective role against vascular toxicity. In mice, Yoda1 co-treatment prevented the long-term cardiac dysfunction observed following sunitinib exposure, and normalized elevations in circulating cardiac stress biomarkers. Single-nuclei multiomic profiling of mouse hearts revealed that sunitinib exposure activated chromatin remodeling and fibrogenic programs, which were reversed with PIEZO1 activation. Human engineered cardiac organoids further demonstrated that sunitinib impaired cardiomyocyte function only in the presence of endothelial cells, confirming a role for disrupted endothelial-cardiomyocyte crosstalk in TKI cardiotoxicity. Together, these findings identify endothelial PIEZO1 as a critical mediator of TKI-induced hypertension and cardiac dysfunction and highlight PIEZO1 activation as a potential therapeutic strategy for protecting cardiovascular health during cancer therapy.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309754">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>7.</strong> â­ <strong>GSE272080 3DæŸ“è‰²è´¨å˜å¼‚åŸºå› å›¾è°±è·¨è¶Š57ç§äººç±»ç»†èƒç±»å‹æ­ç¤ºè‡ªèº«å…ç–«ç–¾ç—…æ˜“æ„Ÿæ€§çš„ç»†èƒå’Œé—ä¼ ç»“æ„[captureC]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€immuneã€immunityã€TMEã€cardiacã€gliomaã€TCGAã€DepMapã€depmapã€Hi-Cã€single.cellã€scRNAã€scDNAã€scATACã€spatialã€Visiumã€genomeã€genomicsã€proteomeã€Seuratã€Scanpyã€methylationã€histoneã€enrichment</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Khanh B Trang ; Megan K Levings ; Struan F Grant ; Andrew D WellsSeries Type : OtherOrganism : Homo sapiensThe genetic basis for many common autoimmune disorders has been uncovered by genome-wide association studies (GWAS), but GWAS do not reveal causal variants, effector genes, or the cell types impacted by disease-associated variation. We have generated 3D genomic datasets consisting of promoter-focused Capture-C, Hi-C, ATAC-seq, and RNA-seq and integrated these data with GWAS of 16 autoimmune traits to physically map disease-associated variants to the genes they likely regulate in over 50 human cell types. These 3D maps of gene cis-regulatory architecture are highly powered to identify the cell types most likely impacted by disease-associated genetic variation compared to 1D genomic features, and tend to implicate different effector genes than eQTL approaches in the same cell types. Most of the variants implicated by these cis-regulatory architectures are highly trait-specific, but nearly half of the target genes connected to these variants are shared across multiple autoimmune disorders in multiple cell types, suggesting a high level of genetic diversity and complexity among autoimmune diseases that nonetheless converge at the level of target gene and cell type. Substantial effector gene sharing led to common enrichment of similar biological networks across disease and cell type, however, trait-specific pathways representing potential areas for disease-specific intervention were identified. To test this, we functionally validated squalene synthase, a cholesterol biosynthetic enzyme encoded by the FDFT1 gene implicated in MS and SLE, as a novel immunomodulatory drug target controlling inflammatory cytokine production by human T cells. These data represent a comprehensive resource for basic discovery of gene cis-regulatory mechanisms, and the analyses reported reveal mechanism by which autoimmune-associated variants act to regulate gene expression, function, and pathology across multiple, distinct tissues and cell types.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE272080">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>8.</strong> â­ <strong>GSE297038 æ”¾åŒ–ç–—é‡ç¼–ç¨‹å®«é¢ˆç™Œè‚¿ç˜¤ç»†èƒå’Œå…ç–«å¾®ç¯å¢ƒ [æ‰¹é‡ RNA æµ‹åº]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€carcinomaã€immuneã€tumor microenvironmentã€TMEã€cardiacã€gliomaã€RNA-seqã€RNAseqã€DNA-seqã€ChIP-seqã€ATAC-seqã€single.cellã€scRNAã€scDNAã€scATACã€spatialã€genomeã€genomicsã€proteomeã€proteomicsã€Seuratã€histone</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Tito A Sandoval ; Yize Li ; Naoshad Muhammad ; Tresha Desai ; Reyka Jayasinghe ; Saman Zeeshan ; Kay Jayachandran ; Matthew Inkman ; Michael R Waters ; Naomi Msengi ; Tyler Mckinnish ; Ibrahim Hatipoglu ; Ana C Paschoalini Mafra ; Muyassar Anwar ; Donghua Hu ; Dhaval Bhatt ; Varintra Lander ; R. Jay Mashl ; Liyun Chen ; Jessika Contreras ; Clifford Robinson ; Sherri R Davies ; Julie Belmar ; Shunqiang Li ; M. Benjamin Major ; David G DeNardo ; Stephanie Markovina ; Brian T Edelson ; Jin Zhang ; Li Ding ; Julie K SchwarzSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensDespite advances in screening and prevention, cervical cancer remains a leading cause of cancer-related deaths worldwide, underscoring the need for better treatments. Here, we present a multi-cohort longitudinal study of human cervical tumors and the tumor microenvironment during chemoradiation therapy (CRT). Integrating RNA sequencing, single-cell transcriptomics, and in vivo validation, we define the cellular and molecular programs shaping cell interactions and document how CRT alters them. We identify multiple therapeutic targets in CRT-resistant tumors, notably MDM2, a key mediator of radiation responses in tumor and immune cells. MDM2 inhibition enhanced radiotherapy effects in HPV-positive, TP53 wild-type cervical cancer cells, improved radiation response and reshaped the immune landscape in preclinical models. These findings highlight the potential of combining MDM2 inhibition with CRT to overcome resistance and improve patient outcomes. Our data provides novel insights into therapy-induced changes in tumor and immune compartments, guiding new strategies against treatment-resistant HPV-positive cancers.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE297038">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>9.</strong> â­ <strong>GSE272172 3DæŸ“è‰²è´¨å˜å¼‚åŸºå› å›¾è°±è·¨è¶Š57ç§äººç±»ç»†èƒç±»å‹æ­ç¤ºè‡ªèº«å…ç–«ç–¾ç—…æ˜“æ„Ÿæ€§çš„ç»†èƒå’Œé—ä¼ ç»“æ„[HiC]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€immuneã€immunityã€TMEã€cardiacã€gliomaã€TCGAã€DepMapã€depmapã€Hi-Cã€single.cellã€scRNAã€scDNAã€scATACã€spatialã€Visiumã€genomeã€genomicsã€proteomeã€Seuratã€Scanpyã€methylationã€histoneã€enrichment</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Khanh B Trang ; Struan F Grant ; Andrew D WellsSeries Type : OtherOrganism : Homo sapiensThe genetic basis for many common autoimmune disorders has been uncovered by genome-wide association studies (GWAS), but GWAS do not reveal causal variants, effector genes, or the cell types impacted by disease-associated variation. We have generated 3D genomic datasets consisting of promoter-focused Capture-C, Hi-C, ATAC-seq, and RNA-seq and integrated these data with GWAS of 16 autoimmune traits to physically map disease-associated variants to the genes they likely regulate in over 50 human cell types. These 3D maps of gene cis-regulatory architecture are highly powered to identify the cell types most likely impacted by disease-associated genetic variation compared to 1D genomic features, and tend to implicate different effector genes than eQTL approaches in the same cell types. Most of the variants implicated by these cis-regulatory architectures are highly trait-specific, but nearly half of the target genes connected to these variants are shared across multiple autoimmune disorders in multiple cell types, suggesting a high level of genetic diversity and complexity among autoimmune diseases that nonetheless converge at the level of target gene and cell type. Substantial effector gene sharing led to common enrichment of similar biological networks across disease and cell type, however, trait-specific pathways representing potential areas for disease-specific intervention were identified. To test this, we functionally validated squalene synthase, a cholesterol biosynthetic enzyme encoded by the FDFT1 gene implicated in MS and SLE, as a novel immunomodulatory drug target controlling inflammatory cytokine production by human T cells. These data represent a comprehensive resource for basic discovery of gene cis-regulatory mechanisms, and the analyses reported reveal mechanism by which autoimmune-associated variants act to regulate gene expression, function, and pathology across multiple, distinct tissues and cell types.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE272172">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>10.</strong> â­ <strong>GSE279819 æ•²ä½ MSLN é€šè¿‡è°ƒèŠ‚è‚¿ç˜¤å¾®ç¯å¢ƒå¢å¼ºæŠ— PD-1 ç–—æ³•åœ¨é«˜çº§åˆ«æµ†æ¶²æ€§åµå·¢ç™Œä¸­çš„ç–—æ•ˆã€‚[ç»†èƒç³»]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€carcinomaã€tumor microenvironmentã€TMEã€cardiacã€gliomaã€kinaseã€TCGAã€Hi-Cã€single.cellã€scRNAã€scDNAã€scATACã€genomeã€genomicsã€proteomeã€Seuratã€Scanpyã€epigeneticã€epigenomeã€methylationã€histoneã€enrichment</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Jiaqi Lu ; Haiou Liu ; Yujing Zhong ; Yiying Wang ; Chenyang WangSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusThe role of MSLN in remodulating tumor microenviroment in high-grade serous ovarian cancer and the underlying mechanisms</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE279819">æŸ¥çœ‹åŸæ–‡</a></li></ul><blockquote><p>ğŸ’¡ è¯¥æ¥æºè¿˜æœ‰ 56 æ¡å†…å®¹ï¼Œè¯¦è§ <a href=#%E6%9B%B4%E5%A4%9A-%E6%95%B0%E6%8D%AE%E5%89%8D%E6%B2%BF>æ–‡æœ«</a></p></blockquote></div></details><details><summary style="text-align:right;direction:rtl;padding:10px 15px;background:linear-gradient(135deg,#f8f9fa 0%,#e9ecef 100%);border-right:4px solid #667eea;font-weight:600;cursor:pointer;margin:15px 0;border-radius:6px">ğŸ”¬ æœŸåˆŠæ–‡ç«  (5æ¡)</summary><div class=details-content markdown=1><h4 id=è¯¦ç»†å†…å®¹å…¨éƒ¨5æ¡>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨5æ¡ï¼‰</h4><p><strong>1.</strong> <strong>ä¸åŒç³–å°¿ç—…ç±»å‹å’Œèƒ°è…ºå¯¼ç®¡è…ºç™Œï¼šå­Ÿå¾·å°”éšæœºåŒ–å’Œé€šè·¯/åŸºå› é›†åˆ†æ</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šé€šè·¯</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: èƒŒæ™¯ ä¸åŒç±»å‹ç³–å°¿ç—…ï¼ˆä»¥ä¸åŒçš„ç—…ç†ç”Ÿç†å­¦å’Œé—ä¼ ç»“æ„ä¸ºç‰¹å¾ï¼‰ä¸èƒ°è…ºå¯¼ç®¡è…ºç™Œ ï¼ˆPDACï¼‰ é£é™©ä¹‹é—´çš„å…³è”å°šä¸æ¸…æ¥šã€‚æ–¹æ³• ç ”ç©¶ 2 å‹ç³–å°¿ç—…ï¼ˆT2Dï¼‰ã€8 ä¸ª T2D æœºåˆ¶ç°‡ã€1 å‹ç³–å°¿ç—…ï¼ˆT1Dï¼‰å’Œå¹´è½»äººæˆç†ŸæœŸç³–å°¿ç—…ï¼ˆMODYï¼‰çš„é—ä¼ æ˜“æ„Ÿæ€§ä¸ PDAC é£é™©çš„å…³è”ã€‚æˆ‘ä»¬å¯¹æ¬§æ´²è¡€ç»Ÿä¸ªä½“çš„ T2Dï¼ˆ242,283 ä¾‹ï¼Œ1,569,734 ä¾‹ï¼‰ã€T1Dï¼ˆ18,942 ä¾‹ï¼Œ501,638 ä¾‹å¯¹ç…§ï¼‰å’Œ PDACï¼ˆ10,244 ä¾‹å’Œ 360,535 ä¾‹å¯¹ç…§ï¼‰ä½¿ç”¨äº†å…¨åŸºå› ç»„å…³è”ç ”ç©¶ ï¼ˆGWASï¼‰ æ±‡æ€»æ°´å¹³ç»Ÿè®¡ã€‚ç»“æœ é‡‡ç”¨ç¨³å¥è°ƒæ•´æ¦‚å†µè¯„åˆ†ï¼ˆMR-RAPSï¼‰æ–¹æ³•è¿›è¡ŒåŒæ ·æœ¬å­Ÿå¾·å°”éšæœºåŒ–ï¼ˆMRï¼‰ç»“æœæ˜¾ç¤ºï¼Œé—ä¼ é¢„æµ‹çš„ T2D ä¸ PDAC é£é™©ï¼ˆOR = 1.10;95% CI 1.05â€“1.15ï¼‰ç›¸å…³ï¼Œå°¤å…¶æ˜¯ T2D è‚¥èƒ–ï¼ˆOR = 1.28;95% CI 1.15â€“1.42ï¼‰å’Œè„‚è‚ªè¥å…»ä¸è‰¯ï¼ˆOR = 1.25;95%</li><li>ğŸ”— <a href=https://m.x-mol.com/paper/1987993557389127680/t>æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>2.</strong> <strong>ä¼˜åŒ–è‚¿ç˜¤è¯ç‰©å¼€å‘ï¼š22å¹´éª¨é«“ç˜¤éšæœºå¯¹ç…§è¯•éªŒçš„ç³»ç»Ÿè¯„ä»·</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè‚¿ç˜¤</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: å¼•è¨€ å°½ç®¡éª¨é«“ç˜¤ä»£è¡¨äº†è‚¿ç˜¤å­¦çš„ä¸€ä¸ªå…³é”®æˆåŠŸæ¡ˆä¾‹ï¼Œä½†å°½ç®¡æ—©æœŸæ´»æ€§è‰¯å¥½ï¼Œä½†ä¸€äº›è¯ç‰©æœªèƒ½è¾¾åˆ°éšæœºå¯¹ç…§è¯•éªŒ ï¼ˆrandomized controlled trialsï¼Œ RCTï¼‰ çš„ä¸»è¦ç»ˆç‚¹ã€‚è¯¥åˆ†ææ—¨åœ¨äº†è§£å¢åŠ éª¨é«“ç˜¤éšæœºå¯¹ç…§è¯•éªŒä¸­è¾¾åˆ°ä¸»è¦ç»ˆç‚¹å¯èƒ½æ€§çš„å› ç´ ã€‚æ–¹æ³• ä½¿ç”¨ MEDLINEã€PubMedã€Embase å’Œ Cochrane Registry ç¡®å®šæˆªè‡³ 2023 å¹´ 10 æœˆå‘è¡¨çš„éª¨é«“ç˜¤éšæœºå¯¹ç…§è¯•éªŒã€‚ç ”ç©¶è¢«åˆ†ä¸ºå¤´å¯¹å¤´ï¼ˆç”¨ä¸€ç§æ–¹æ¡ˆä»£æ›¿å¦ä¸€ç§æ–¹æ¡ˆï¼‰æˆ–é™„åŠ ç–—æ³•ï¼ˆåœ¨ç°æœ‰æ–¹æ¡ˆä¸­æ·»åŠ ä¸€ç§è¯ç‰©ï¼‰ã€‚å¦‚æœè¯•éªŒå¯¹ä¸»è¦ç»“å±€å…·æœ‰ç»Ÿè®¡å­¦æ„ä¹‰ï¼Œåˆ™è®¤ä¸ºè¯•éªŒæ˜¯æˆåŠŸçš„ã€‚é€»è¾‘å›å½’ç¡®å®šäº†è¾¾åˆ°è¯•éªŒç»ˆç‚¹çš„é¢„æµ‹å› ç´ ã€‚ç»“æœ å…±çº³å…¥ 123 é¡¹ RCT çš„ 145 ç¯‡æ¯”è¾ƒã€‚åœ¨å¤šå˜é‡åˆ†æä¸­ï¼Œåªæœ‰ä¸¤ä¸ªå› ç´ ä¸è¾¾åˆ°ä¸»è¦ç»ˆç‚¹ç‹¬ç«‹ç›¸å…³ã€‚å—è¯•è€…å¹´é¾„ä¸­ä½æ•°è¶Šé«˜ï¼Œè¾¾åˆ°ä¸»è¦ç»ˆç‚¹çš„å‡ ç‡è¶Šä½ï¼ˆOR/1 å¹´å¢åŠ ï¼Œ0.90,95%CIï¼š0.83-0.98ï¼‰ã€‚æ€»ç”Ÿå­˜æœŸ</li><li>ğŸ”— <a href=https://m.x-mol.com/paper/1987993540737740800/t>æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>3.</strong> <strong>æ›²å¦¥ç å•æŠ— Deruxtecan ï¼ˆT-DXdï¼‰ é€šè¿‡ HER2 è¡¨è¾¾å’Œç»“åˆä¸§å¤±äº§ç”Ÿè€è¯æ€§</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šè€è¯</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: T-DXd å¯¹ HER2 é˜³æ€§å’Œ HER2 ä½è½¬ç§»æ€§ä¹³è…ºç™Œå…·æœ‰ä¸´åºŠç›Šå¤„ã€‚ç„¶è€Œï¼Œéšç€æ—¶é—´çš„æ¨ç§»ï¼Œå¤§å¤šæ•°æ‚£è€…ä¼šå‡ºç°æ²»ç–—è€è¯æ€§ï¼Œè€è¯æœºåˆ¶å®šä¹‰ä¸æ˜ç¡®ã€‚é€šè¿‡å¯¹ T-DXd æ²»ç–—å‰åé…å¯¹æ‚£è€…æ ‡æœ¬çš„åˆ†å­è¡¨å¾ï¼Œæˆ‘ä»¬å‘ç° 49% çš„ç—…ä¾‹åœ¨è¿›å±•æ—¶ HER2 è¡¨è¾¾æ˜¾ç€ä¸‹é™ï¼Œå…¶ä¸­ 52% çš„ç—…ä¾‹è¡¨ç°å‡º HER2 å®Œå…¨ä¸¢å¤±ã€‚ä½¿ç”¨åŒåŸºå› æ¨¡å‹ç³»ç»Ÿï¼Œæˆ‘ä»¬è¯æ˜ HER2 è¡¨è¾¾çš„é™ä½å¯¹åº”äº T-DXd å†…åŒ–çš„å‡å°‘å’Œç”¨äºæŠ‘åˆ¶è‚¿ç˜¤ç”Ÿé•¿çš„è¯ç‰© IC50 çš„æ˜¾ç€å¢åŠ ã€‚æˆ‘ä»¬è¿›ä¸€æ­¥é‰´å®šå¹¶éªŒè¯äº†æ›²å¦¥ç å•æŠ—ç»“åˆç•Œé¢ï¼ˆV597M å’Œ P593Rï¼‰ä¸­ä¿ƒè¿› T-DXd è€è¯æ€§çš„ HER2 çªå˜ã€‚ä½œä¸ºå…‹æœ T-DXd ç»“åˆå’Œå†…åŒ–å—æŸçš„ç­–ç•¥ï¼Œæˆ‘ä»¬æµ‹è¯•äº† T-DXd ä¸ TROP2 å®šå‘ ADC çš„ä½å‰‚é‡ç»„åˆï¼Œå‘ç°è¿™äº›å¯ä»¥æ›´å‡åŒ€åœ°é€’é€ DXd æœ‰æ•ˆè½½è·ï¼Œä»è€Œå…‹æœç”± HER2 ä¸¢å¤±ä»‹å¯¼çš„é˜»åŠ›ã€‚</li><li>ğŸ”— <a href=https://m.x-mol.com/paper/1987999846458568704/t>æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>4.</strong> <strong>å¤´é¢ˆéƒ¨é³çŠ¶ç»†èƒç™Œçš„æ–°è¾…åŠ©å…ç–«æ²»ç–—ï¼šå½“å‰è¯æ®å’Œæœªæ¥å±•æœ›</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šå…ç–«</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: å¤´é¢ˆéƒ¨é³çŠ¶ç»†èƒç™Œ ï¼ˆHNSCCï¼‰ æ˜¯ä¸€ç§é«˜åº¦ä¾µè¢­æ€§çš„æ¶æ€§è‚¿ç˜¤ã€‚ä¼ ç»Ÿæ²»ç–—æ–¹æ³•å¯¹å±€éƒ¨æ™šæœŸ HNSCC æ‚£è€…ç–—æ•ˆæœ‰é™ï¼Œæ–°è¾…åŠ©å…ç–«æ²»ç–—æˆä¸ºæ–°çš„å¸Œæœ›ã€‚ç„¶è€Œï¼Œç›®å‰æ–°è¾…åŠ©å…ç–«æ²»ç–— HNSCC çš„ç»“æœå°šä¸ç†æƒ³ï¼Œè¿«åˆ‡éœ€è¦æ”¹è¿›ã€‚æœ¬æ–‡å…¨é¢ç»¼è¿°äº†æ–°è¾…åŠ©å…ç–«æ²»ç–—åœ¨ HNSCC æ²»ç–—é¢†åŸŸçš„ä¸´åºŠç ”ç©¶è¿›å±•ã€‚é€šè¿‡ç»¼åˆå…ç–«å¾®ç¯å¢ƒè°ƒæ§æœºåˆ¶çš„è§‚ç‚¹ï¼Œæˆ‘ä»¬æå‡ºäº†æé«˜æ–°è¾…åŠ©å…ç–«æ²»ç–—å¯¹ HNSCC æ‚£è€…ç–—æ•ˆçš„æœªæ¥ç ”ç©¶æ–¹å‘ã€‚</li><li>ğŸ”— <a href=https://m.x-mol.com/paper/1988087372061978624/t>æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>5.</strong> <strong>é‡æ–°å®šä¹‰å†œæ‘ï¼šé‡‡ç”¨åŸºäºèº«ä»½å’Œç¤¾åŒºå‚ä¸çš„æ–¹æ³•æ¥å®šä¹‰å†œæ‘ç™Œç—‡å·®å¼‚ã€‚</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šç™Œç—‡</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: ç¾å›½çš„å†œæ‘å¥åº·å·®è·ä»ç„¶çŸ¥ä¹‹ç”šå°‘ï¼Œéƒ¨åˆ†åŸå› æ˜¯â€œå†œæ‘â€çš„å®šä¹‰ä¸ä¸€è‡´ï¼Œä»¥åŠæœªèƒ½æ•´åˆåœ°ç†å’Œç¤¾ä¼šå»ºæ„çš„åœ°æ–¹ç»´åº¦ã€‚æœ¬è¯„è®ºå€Ÿé‰´äº† 2024 å¹´ç¤¾åŒºå’Œå†œæ‘åŒ»ç–—ä¿å¥è½¬å‹ ï¼ˆTCRHï¼‰ ä¼šè®®â€œè§£å†³å†œæ‘ç¤¾åŒºç™Œç—‡é¢„é˜²ã€æ§åˆ¶å’Œç”Ÿå­˜å¤šæ ·æ€§â€å°ç»„è®¨è®ºæœŸé—´åˆ†äº«çš„è§è§£ã€‚å°ç»„æˆå‘˜å¼ºè°ƒäº†å½“å‰åŸä¹¡åˆ†ç±»ç³»ç»Ÿçš„å±€é™æ€§ï¼Œè¿™äº›ç³»ç»Ÿå¾€å¾€å¿½è§†äº†å†œæ‘äººå£çš„äº¤å‰èº«ä»½ã€æ–‡åŒ–å¼‚è´¨æ€§å’Œç”Ÿæ´»ç»å†ã€‚ä»–ä»¬ä¸»å¼ å°†åŸºäºç¤¾åŒºçš„å‚ä¸å¼ç ”ç©¶ ï¼ˆCBPRï¼‰ å’ŒåŸºäºèº«ä»½çš„æ–¹æ³•ç»“åˆèµ·æ¥ï¼Œä»¥æ›´å…¨é¢åœ°å®šä¹‰å†œæ‘ã€‚æ­¤ç±»æ–¹æ³•ä¼˜å…ˆè€ƒè™‘è‡ªæˆ‘è®¤åŒã€å¥åº·çš„ç¤¾ä¼šå†³å®šå› ç´  ï¼ˆSDOHï¼‰ å’Œæœ¬åœ°åŒ–çŸ¥è¯†ï¼Œä»è€Œå¯ä»¥æ›´å‡†ç¡®åœ°è¯„ä¼°ç™Œç—‡å·®å¼‚å¹¶åˆ¶å®šå…¬å¹³çš„å¹²é¢„æªæ–½ã€‚è¯¥è¯„è®ºæ¦‚è¿°äº†åœ°çƒç‰©ç†å’ŒåŸºäºäººå£æ™®æŸ¥çš„æŒ‡æ ‡è™½ç„¶æ–¹ä¾¿ï¼Œä½†å¦‚ä½•æ­ªæ›²å†œæ‘ç¤¾åŒºï¼Œå¹¶æ— æ„ä¸­ä½¿ç™Œç—‡æŠ¤ç†å¯åŠæ€§ã€ç»“æœå’Œæ”¿ç­–æ–¹é¢çš„å·®å¼‚é•¿æœŸå­˜åœ¨ã€‚ä½œè€…ä¸»å¼ ä»¥èº«ä»½å’Œç¤¾åŒºä¸ºä¸­å¿ƒçš„å†œæ‘æ¦‚å¿µåŒ–ï¼Œè¿™ç§æ¦‚å¿µæ˜¯åŠ¨æ€çš„ã€åŒ…å®¹çš„ï¼Œå¹¶å¯¹å†œæ‘ç”Ÿæ´»çš„å¤æ‚æ€§åšå‡ºååº”ã€‚</li><li>ğŸ”— <a href=https://m.x-mol.com/paper/1988000556768145408/t>æŸ¥çœ‹åŸæ–‡</a></li></ul></div></details><details><summary style="text-align:right;direction:rtl;padding:10px 15px;background:linear-gradient(135deg,#f8f9fa 0%,#e9ecef 100%);border-right:4px solid #667eea;font-weight:600;cursor:pointer;margin:15px 0;border-radius:6px">ğŸ“Š å­¦ç‚¹ç”Ÿä¿¡ (1æ¡)</summary><div class=details-content markdown=1><h4 id=è¯¦ç»†å†…å®¹å…¨éƒ¨1æ¡>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨1æ¡ï¼‰</h4><p><strong>1.</strong> <strong>ä¸€äº›çœ‹ä¼¼æ— ç”¨å´åˆå®ç”¨çš„ R å‡½æ•°â€”â€”åœ¨æ•°å­— Ï€ ä¸­æŸ¥æ‰¾å­å­—ç¬¦ä¸²</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šTME</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šThey say that number Pi holds all infinite possibilities, all the words, all the combinations. Well, easier said to be done. So letâ€™s put this to a test. This is my translational table. We will do this in the followingâ€¦Read more â€º Continue reading: Little useless-useful R functions â€“ Finding substrings in number Pi</li><li>ğŸ”— <a href=https://www.r-bloggers.com/2025/11/little-useless-useful-r-functions-finding-substrings-in-number-pi/>æŸ¥çœ‹åŸæ–‡</a></li></ul></div></details><details><summary style="text-align:right;direction:rtl;padding:10px 15px;background:linear-gradient(135deg,#f8f9fa 0%,#e9ecef 100%);border-right:4px solid #667eea;font-weight:600;cursor:pointer;margin:15px 0;border-radius:6px">ğŸ§ª åšå®¢æ›´æ–° (2æ¡)</summary><div class=details-content markdown=1><h4 id=è¯¦ç»†å†…å®¹å…¨éƒ¨2æ¡>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨2æ¡ï¼‰</h4><p><strong>1.</strong> â­ <strong>MntJULiP å’Œ Jutils â€“ åŸºäºåå˜é‡çš„ RNA-seq æ•°æ®å·®å¼‚å‰ªæ¥åˆ†æ</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šTCGAã€RNA-seqã€RNAseqã€DNA-seqã€ATAC-seqã€scRNAã€scATAC</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šUsing RNA sequencing, researchers from Johns Hopkins University developed MntJULiP and Jutils to accurately detect RNA splicing changes influenced by age, sex, and other biological&mldr;</li><li>ğŸ”— <a href=https://www.rna-seqblog.com/mntjulip-and-jutils-differential-splicing-analysis-of-rna-seq-data-with-covariates/>æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>2.</strong> <strong>å¥³æ€§æ‚£ä¸Šä¸¥é‡æ–°å† åé—ç—‡çš„å‡ ç‡æ˜¯ç”·æ€§çš„ä¸‰å€ï¼šåŸå› å¦‚ä¸‹</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šTMEã€histone</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šResearchers used RNA sequencing to uncover immune, hormonal, and metabolic differences explaining why women with long COVID often experience more severe and persistent symptoms than men&mldr;</li><li>ğŸ”— <a href=https://www.rna-seqblog.com/women-are-three-times-more-likely-than-men-to-get-severe-long-covid-heres-why/>æŸ¥çœ‹åŸæ–‡</a></li></ul></div></details><h2 id=-å…³é”®è¯ç»Ÿè®¡>ğŸ“Š å…³é”®è¯ç»Ÿè®¡</h2><table><thead><tr><th>å…³é”®è¯</th><th>å‡ºç°æ¬¡æ•°</th></tr></thead><tbody><tr><td>TME</td><td>62</td></tr><tr><td>scRNA</td><td>56</td></tr><tr><td>genome</td><td>56</td></tr><tr><td>scDNA</td><td>53</td></tr><tr><td>Seurat</td><td>52</td></tr><tr><td>glioma</td><td>49</td></tr><tr><td>scATAC</td><td>48</td></tr><tr><td>TCGA</td><td>44</td></tr><tr><td>cancer</td><td>38</td></tr><tr><td>genomics</td><td>36</td></tr><tr><td>tumor</td><td>35</td></tr><tr><td>spatial</td><td>32</td></tr><tr><td>cardiac</td><td>27</td></tr><tr><td>immune</td><td>26</td></tr><tr><td>histone</td><td>25</td></tr><tr><td>proteome</td><td>24</td></tr><tr><td>RNAseq</td><td>21</td></tr><tr><td>DepMap</td><td>18</td></tr><tr><td>depmap</td><td>18</td></tr><tr><td>single.cell</td><td>18</td></tr></tbody></table><hr><h2 id=-æ›´å¤šå†…å®¹>ğŸ“ æ›´å¤šå†…å®¹</h2><details><summary><a name=æ›´å¤š-å…¬ä¼—å·></a>ğŸ“° å…¬ä¼—å· å…¶ä»–å†…å®¹ (7æ¡)</summary><div class=details-content markdown=1><ul><li><a href="https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&amp;mid=2247503930&amp;idx=4&amp;sn=1767c51851d404941197662854064212">æœ€æ–°9.4åˆ†å•åŸºå› çº¯ç”Ÿä¿¡ï¼Œç»å…¸çš„æ€è·¯ä¸ºä½•èƒ½å‘è¡¨è¿™ä¹ˆé«˜åˆ†ï¼Œä½ è¡Œä½ ä¹Ÿä¸Šï¼</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=Mzg3NDE3NTk4MA==&amp;mid=2247503930&amp;idx=3&amp;sn=6a0cac8379033db41cdf20e6b73c6453">è°è¯´å•åŸºå› æ²¡å‰é€”ï¼Œç»“åˆå•ç»†èƒï¼Œç©ºè½¬å’Œå®éªŒéªŒè¯ï¼Œç…§æ ·å‘8åˆ†1åŒºæ–‡ç« ï¼</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzkwMzY2NjkwNg==&amp;mid=2247495506&amp;idx=1&amp;sn=2810e4b1f970d0c2087ff1a8900db795">Science |è¿™ç§å‘ç°æœ‰æ„æ€ï¼Œè‚ç»†èƒç™Œçš„èµ·æºä¸è‚è„ä»£è°¢åˆ†åŒºå¯†åˆ‡ç›¸å…³ï¼Œå…¶ä»–ç™Œç§æ˜¯å¦ä¹Ÿæœ‰è¿™ç§åŒºåŸŸç‰¹æ€§å‘¢ï¼Ÿ</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzkxMDY1MjU1OA==&amp;mid=2247488496&amp;idx=1&amp;sn=d8e474f00d0f640153e49bf38a03e7c6">æ–‡çŒ®åˆ†äº« | ã€Natureé‡ç£…å‘å¸ƒã€‘ç©ºé—´ä¸‰ç»„å­¦å…¨æ™¯å¼ç»˜åˆ¶å¤§è„‘å‘è‚²ä¸ç¥ç»ç‚ç—‡åŠ¨æ€å›¾è°±</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzU5MDcwNzg0MA==&amp;mid=2247657588&amp;idx=2&amp;sn=ea98057240951d29600d30eb64e7333f">Stem Cell Repï¼šåˆ©ç”¨äººèƒƒç±»å™¨å®˜ç§»æ¤å®ç°èƒƒæºæ€§èƒ°å²›ç´ åˆ†æ³Œç»†èƒçš„ä½“å†…è¯±å¯¼ | Cell Pressè®ºæ–‡é€Ÿé€’</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MjM5MzQ4NTk4MA==&amp;mid=2656509414&amp;idx=1&amp;sn=2eed33d4a3226dd3908b9d9093aa7930">è‚ºç™Œæ²»ç–—æ–°çªç ´ï¼ä¸Šæµ·å¸‚è‚ºç§‘åŒ»é™¢ä»»èƒœç¥¥/é™ˆæ–Œ/è®¸äºšèç­‰æ¶ˆèæœ¯è”åˆå…ç–«ç–—æ³•æ˜¾ç€å»¶é•¿æ™šæœŸè‚ºç™Œæ‚£è€…ç”Ÿå­˜æœŸï¼Œä¸”å®‰å…¨æ€§å¯æ§</a></li><li><a href="https://mp.weixin.qq.com/s?__biz=MzAwMzY4MTYxNw==&amp;mid=2655821349&amp;idx=2&amp;sn=4a06dc5d104888b7f1f2f1b39d824ebf">å¦‚æœä½ æƒ³ä»ä»£è°¢è§’åº¦ç”³è¯·å›½è‡ªç„¶ï¼Œæ¨èå››ä¸ªé«˜ç«¯æ€è·¯ç»™ä½ â€¦â€¦</a></li></ul></div></details><details><summary><a name=æ›´å¤š-æ•°æ®å‰æ²¿></a>ğŸ§¬ æ•°æ®å‰æ²¿ å…¶ä»–å†…å®¹ (56æ¡)</summary><div class=details-content markdown=1><ul><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE297041">GSE297041 æ”¾åŒ–ç–—é‡ç¼–ç¨‹å®«é¢ˆç™Œè‚¿ç˜¤ç»†èƒå’Œå…ç–«å¾®ç¯å¢ƒ [scRNA-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE283108">GSE283108 PML-mTOR-RONIN æ ¸å¤åˆç‰©åœ¨ä¸‰é˜´æ€§ä¹³è…ºç™Œä¸­å¯¹æ ¸ç³–ä½“åŸºå› è¡¨è¾¾å’Œè¡°è€çš„è°ƒæ§ [ChIP-seq_mTOR]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE283107">GSE283107 PML-mTOR-RONIN æ ¸å¤åˆç‰©åœ¨ä¸‰é˜´æ€§ä¹³è…ºç™Œä¸­å¯¹æ ¸ç³–ä½“åŸºå› è¡¨è¾¾å’Œè¡°è€çš„è°ƒæ§ [ChIP-seq_PML]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE279226">GSE279226 æ•²ä½ MSLN é€šè¿‡è°ƒèŠ‚è‚¿ç˜¤å¾®ç¯å¢ƒå¢å¼ºæŠ— PD-1 ç–—æ³•åœ¨é«˜çº§åˆ«æµ†æ¶²æ€§åµå·¢ç™Œä¸­çš„ç–—æ•ˆã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE297276">GSE297276 æ•´ä½“æˆåƒæ˜¾ç¤ºï¼Œè¡€ç®¡å†…å¢æ®–ä¿ƒè¿›äº†æ–°å‹éšçƒèŒè„‘ä¾µè¢­è¿‡ç¨‹ä¸­å­ç»†èƒçš„è·¨å†…çš®è¿ç§»</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE283106">GSE283106 PML-mTOR-RONIN æ ¸å¤åˆç‰©åœ¨ä¸‰é˜´æ€§ä¹³è…ºç™Œä¸­å¯¹æ ¸ç³–ä½“åŸºå› è¡¨è¾¾å’Œè¡°è€çš„è°ƒæ§ [RNA-seq_shPML]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309753">GSE309753 å¤šå°ºåº¦åˆ†æé…ªæ°¨é…¸æ¿€é…¶æŠ‘åˆ¶å‰‚å¿ƒè„æ¯’æ€§æ­ç¤ºæœºæ¢°æ•æ„Ÿæ€§ç¦»å­é€šé“ PIEZO1 å…·æœ‰å¿ƒè„ä¿æŠ¤ä½œç”¨</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE304531">GSE304531 è‚ºç‚åå¹¼é¼ çš„å¹´é¾„ä¾èµ–æ€§å…ç–«ååº”å’Œé©»ç•™ç»†èƒåŠ¨æ€ [RNA-Seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE266320">GSE266320 é€šè¿‡å•ç»†èƒå¤šè¡¨è§‚åŸºå› ç»„æ•°æ®æ•´åˆæ¡†æ¶é‡å»ºè¡¨è§‚åŸºå› ç»„åŠ¨æ€</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309044">GSE309044 è‚ç»†èƒç™Œçš„èµ·æºå—ä»£è°¢åˆ†åŒºè°ƒæ§ [å•æ ¸åŸºå› åˆ†å‹]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE282160">GSE282160 å¤šåŠŸèƒ½åˆ†å­å·¥å…·å¯å®ç°æ¤ç‰©ä¸­å¯å®šåˆ¶çš„DNAç”²åŸºåŒ–ç¼–è¾‘ [ATAC-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE271241">GSE271241 åŸå§‹å¤šèƒ½æ€§çš„é€€å‡ºåŒ…å«ä¸€ä¸ªç”±ä»£è°¢è¯±å¯¼çš„ç«¯ç²’ç¨³æ€æ£€æŸ¥ç‚¹ã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE308568">GSE308568 è‚ç»†èƒç™Œçš„èµ·æºå—ä»£è°¢åˆ†åŒºè°ƒæ§ [RNA-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE299620">GSE299620 cFLIPæŠ‘åˆ¶ç”±caspase-8 D387Aè‡ªèº«åŠ å·¥å—æŸé©±åŠ¨çš„Caspase-1å’ŒMLKLéä¾èµ–æ€§å›´äº§æœŸè‡´æ­»æ€§</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE296246">GSE296246 ä¿å®ˆçš„C2H2é”ŒæŒ‡è›‹ç™½Rel1å°†æ ¸ç³–ä½“ç”Ÿç‰©åˆæˆä¸æ™®éå­˜åœ¨çš„äººç±»çœŸèŒç—…åŸä½“çš„æ€§å‘è‚²å’Œç¯å¢ƒåº”æ¿€ååº”è”ç³»èµ·æ¥</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE300073">GSE300073 ä¸çŠ¶ç—…æ¯’æ„ŸæŸ“ç ´åäººiPSCè¡ç”Ÿè‚ é“ç±»å™¨å®˜çš„ä¸Šçš®å±éšœåŠŸèƒ½å’Œç¦»å­è½¬è¿</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298600">GSE298600 ä¸çŠ¶ç—…æ¯’æ„ŸæŸ“ç ´åäººiPSCè¡ç”Ÿè‚ é“ç±»å™¨å®˜çš„ä¸Šçš®å±éšœåŠŸèƒ½å’Œç¦»å­è½¬è¿</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE282098">GSE282098 è‡ªé—­ç—‡å°‘çªèƒ¶è´¨ç»†èƒå‡è¯´ï¼šä¸»è°ƒæ§åŸºå›  Baf155 çš„ä¸»è¦ä½œç”¨ [ChIP-Seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE275066">GSE275066 åŸºäºRNAæµ‹åºæ•°æ®çš„NAT10æŠ‘åˆ¶å‰‚ï¼ˆé‡å¡‘ç´ ï¼‰å¯¹ä¸˜è„‘å‡ºè¡€æ²»ç–—ä¸­ç‚ç—‡ç›¸å…³åŸºå› çš„å½±å“</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE307131">GSE307131 äººç±»ç™½ç»†èƒä¸­E3æ³›ç´ è¿æ¥é…¶CBLçš„ä½“ç»†èƒç¼ºé™·ä¼šæŸå®³Bç»†èƒè€ŒéTç»†èƒçš„å‘è‚²å’ŒåŠŸèƒ½</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE283109">GSE283109 PML-mTOR-RONINæ ¸å¤åˆç‰©åœ¨ä¸‰é˜´æ€§ä¹³è…ºç™Œä¸­å¯¹æ ¸ç³–ä½“åŸºå› è¡¨è¾¾å’Œè¡°è€çš„è°ƒæ§</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE281598">GSE281598 èƒƒæ—è·¯æ‰‹æœ¯è¯±å¯¼æŒç»­æ€§è‚ é“é€‚åº”å’Œç‹¬ç‰¹çš„ç³–å°¿ç—…ç¼“è§£ç›¸å…³ä»£è°¢åŸºå› è°ƒæ§</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE282162">GSE282162 å¤šåŠŸèƒ½åˆ†å­å·¥å…·å¯å®ç°æ¤ç‰©ä¸­å¯å®šåˆ¶çš„DNAç”²åŸºåŒ–ç¼–è¾‘ [BiSulfite-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE282885">GSE282885 å•ç»†èƒåˆ†ææ­ç¤ºç˜¢ç—•ç–™ç˜©ä¸æ­£å¸¸äººä½“ç»„ç»‡ä¹‹é—´çš„è½¬å½•ç»„å·®å¼‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE291344">GSE291344 è½¬å½•å› å­ HHEX å’Œé›„æ¿€ç´ å—ä½“ (AR) é©±åŠ¨å°é¼ è‚¾ä¸Šè…ºæ€§äºŒæ€æ€§</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE272270">GSE272270 å¹½é—¨èºæ†èŒè¯±å¯¼çš„PPFIA4ä¿ƒè¿›èƒƒç‚å’Œèƒƒç»†èŒå®šæ¤</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE308959">GSE308959 è‚ç»†èƒç™Œçš„èµ·æºå—ä»£è°¢åˆ†åŒºè°ƒæ§ [Xenium]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE295484">GSE295484 è‚ºç‚åå¹¼é¼ çš„å¹´é¾„ä¾èµ–æ€§å…ç–«ååº”å’Œé©»ç•™ç»†èƒåŠ¨æ€</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE218697">GSE218697 æ­£å¸¸è‘¡è„ç³–è€é‡ (NGT) å’Œå¦Šå¨ æœŸç³–å°¿ç—… (GDM) å­•å¦‡çš„ RNA æµ‹åºæ•°æ®</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE308969">GSE308969 è‚ç»†èƒç™Œçš„èµ·æºå—ä»£è°¢åˆ†åŒºè°ƒæ§</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE225200">GSE225200 REV-ERBÎ± è°ƒèŠ‚ç‚ç—‡æ€§è‚ ç—…ä¸­çš„è°ƒèŠ‚æ€§ T ç»†èƒåŠŸèƒ½ [RNA-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE282099">GSE282099 è‡ªé—­ç—‡å°‘çªèƒ¶è´¨ç»†èƒå‡è¯´ï¼šä¸»è°ƒæ§åŸºå›  Baf155 çš„ä¸»è¦ä½œç”¨ [RNA-Seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE256014">GSE256014 æ¥è‡ªç»†èƒç³»å’Œåˆ†ç¦»çš„å°é¼ å’Œç‰ç±³ç»„ç»‡çš„å•ç»†èƒ RNA æ•°æ®é›†</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE255769">GSE255769 å¤šèƒºä¾èµ–æ€§ä»£è°¢å±è”½è°ƒæ§é€‰æ‹©æ€§å‰ªæ¥</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE308451">GSE308451 CDK4/6 å’Œ SHP2 ä»‹å¯¼ BRAF/MEK æŠ‘åˆ¶å‰‚åœ¨ 2 ç±»å’Œ 3 ç±» BRAF çªå˜ç™Œç—‡ä¸­çš„è€è¯æ€§</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE286346">GSE286346 è‚Œè…±å•ç»†èƒæ°´å¹³åŸºå› è¡¨è¾¾è°±åˆ†æï¼ˆæ–°ç”Ÿå„¿æˆ–æˆäººæ ·æœ¬ï¼Œæœ‰æˆ–æ— æŸä¼¤ï¼‰</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE226454">GSE226454 èƒšçŠ¶ä½“åœ¨ç¼ºæ°§æ¡ä»¶ä¸‹çš„å•ç»†èƒè½¬å½•ç»„åˆ†æ</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE307044">GSE307044 Optineurin å¡‘é€  BV2 å°èƒ¶è´¨ç»†èƒçš„åŸºç¡€è½¬å½•ç»„å’Œ LPS è¯±å¯¼çš„è½¬å½•ç»„</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE283595">GSE283595 ç­‰ä½åŸºå› ç‰¹å¼‚æ€§ ApoE é€šè¿‡ Lrp8 ä»‹å¯¼çš„ç¥ç»å…ƒä½œç”¨å¢å¼ºè„Šé«“æŸä¼¤åçš„è½´çªå†ç”Ÿå’ŒåŠŸèƒ½æ¢å¤</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE281775">GSE281775 è€å¹´å’Œå¹´è½»å°é¼ å¿ƒè„çš„è½¬å½•ç»„åˆ†æ</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE281772">GSE281772 è€å¹´å’Œå¹´è½»å°é¼ å¿ƒè„çš„è½¬å½•ç»„åˆ†æ [scMulti-ome]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE281602">GSE281602 è€å¹´å’Œå¹´è½»å°é¼ å¿ƒè„çš„è½¬å½•ç»„åˆ†æ [RRBS]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE248148">GSE248148 é‰´å®šå— Ppp2ca è°ƒæ§çš„æ”¹å˜åŸºå›  [RNA-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE218909">GSE218909 æœ‰ç—‡çŠ¶å’Œæ— ç—‡çŠ¶å®¿ä¸»å¯¹æ ¸ç›˜èŒçš„ååº”</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE244943">GSE244943 DPP4æŠ‘åˆ¶å‰‚åœ¨å…¨èº«ç‚ç—‡æœŸé—´ä¿æŠ¤è¡€ç®¡å±éšœå®Œæ•´æ€§ - ç¬¬2æ‰¹</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE244815">GSE244815 DPP4æŠ‘åˆ¶å‰‚åœ¨å…¨èº«ç‚ç—‡æœŸé—´ä¿æŠ¤è¡€ç®¡å±éšœå®Œæ•´æ€§ - æ‰¹æ¬¡1</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE225202">GSE225202 REV-ERBÎ± è°ƒèŠ‚ç‚ç—‡æ€§è‚ ç—…ä¸­çš„è°ƒèŠ‚æ€§ T ç»†èƒåŠŸèƒ½ [CUT&amp;RUN]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE291736">GSE291736 ç»†èƒå¤– BRICK1 é©±åŠ¨å¿ƒè‚Œæ¢—æ­»åçš„å¿ƒè„ä¿®å¤</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE282062">GSE282062 é‚»è¿‘æ ‡è®°æ­ç¤º 14-3-3 è›‹ç™½ YWHAB åœ¨ä¹³è…ºç™Œ CDK4/6 æŠ‘åˆ¶å‰‚è€è¯ä¸­çš„ä½œç”¨</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE248146">GSE248146 è¯†åˆ«å— Ppp2ca åŸºå› å½±å“çš„ä¹™é…°åŒ– H3K27 çš„åŸºå› ç»„å æ®ä½ç‚¹ [CUT&amp;RUN]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE291472">GSE291472 Hhex å’Œ AR ç¼ºå¤±å¯¹å°é¼ è‚¾ä¸Šè…ºåŸºå› è¡¨è¾¾çš„å½±å“</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE225203">GSE225203 REV-ERBÎ± è°ƒèŠ‚ç‚ç—‡æ€§è‚ ç—…ä¸­çš„è°ƒèŠ‚æ€§ T ç»†èƒåŠŸèƒ½</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE248147">GSE248147 é‰´å®šåŸºå› ç»„ä¸­çš„ Ppp2ca ç»“åˆä½ç‚¹ [CUT&amp;TAG]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE217972">GSE217972 H3K9 ä¸‰ç”²åŸºåŒ–é€šè¿‡æŠ‘åˆ¶ Tfr1 è°ƒæ§ç¥ç»å…ƒé“æ­»äº¡</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE303411">GSE303411 FSP1 å’Œç»„è›‹ç™½å»ä¹™é…°åŒ–é…¶æŠ‘åˆ¶ç™Œç»†èƒæŒç»­æ€§é“æ­»äº¡</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE293804">GSE293804 è‚Œç»†èƒä¸­ Deaf1 çš„ ChIP-seq</a></li></ul></div></details><hr><p><em>ğŸ“… æŠ¥å‘Šç”Ÿæˆæ—¶é—´ï¼š2025-11-12 00:29</em><br><em>ğŸ¤– ç”± GitHub Actions è‡ªåŠ¨ç”Ÿæˆ</em></p></div><footer class=post__footer><div class="post__tags tags clearfix"><svg class="tags__badge icon icon-tag" width="16" height="16" viewBox="0 0 32 32"><path d="M4 0h8s2 0 4 2l15 15s2 2 0 4L21 31s-2 2-4 0L2 16s-2-2-2-4V3s0-3 4-3m3 10a3 3 0 000-6 3 3 0 000 6"/></svg><ul class=tags__list><li class=tags__item><a class="tags__link btn" href=../../../tags/research/ rel=tag>Research</a></li><li class=tags__item><a class="tags__link btn" href=../../../tags/daily/ rel=tag>Daily</a></li><li class=tags__item><a class="tags__link btn" href=../../../tags/week462025/ rel=tag>Week462025</a></li></ul></div></footer></article></main><div class="authorbox clearfix"><div class=authorbox__header><span class=authorbox__name>About Bloger</span></div></div><nav class="pager flex"><div class="pager__item pager__item--prev"><a class=pager__link href=../../../posts/dailyreports/2025-11-11/ rel=prev><span class=pager__subtitle>Â«&#8201;Previous</span><p class=pager__title>ç§‘ç ”æ—¥æŠ¥ 2025-11-11</p></a></div></nav><section class=comments><div id=disqus_thread></div><script>window.disqus_config=function(){},function(){if(["localhost","127.0.0.1"].indexOf(window.location.hostname)!=-1){document.getElementById("disqus_thread").innerHTML="Disqus comments not available by default when the website is previewed locally.";return}var t=document,e=t.createElement("script");e.async=!0,e.src="//kkitown.disqus.com/embed.js",e.setAttribute("data-timestamp",+new Date),(t.head||t.body).appendChild(e)}()</script><noscript>Please enable JavaScript to view the <a href=https://disqus.com/?ref_noscript>comments powered by Disqus.</a></noscript><a href=https://disqus.com class=dsq-brlink>comments powered by <span class=logo-disqus>Disqus</span></a></section></div><aside class=sidebar><div class="widget-search widget"><form class=widget-search__form role=search method=get action=https://google.com/search><input class=widget-search__field type=search placeholder=Searchâ€¦ name=q aria-label=Searchâ€¦>
<input class=widget-search__submit type=submit value=Search>
<input type=hidden name=sitesearch value=https://ixxmu.github.io/></form></div><div class="widget-recent widget"><h4 class=widget__title>Recent Posts</h4><div class=widget__content><ul class=widget__list><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2025-11-12/>ç§‘ç ”æ—¥æŠ¥ 2025-11-12</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2025-11-11/>ç§‘ç ”æ—¥æŠ¥ 2025-11-11</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2025-11-10/>ç§‘ç ”æ—¥æŠ¥ 2025-11-10</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2025-11-09/>ç§‘ç ”æ—¥æŠ¥ 2025-11-09</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2025-11-08/>ç§‘ç ”æ—¥æŠ¥ 2025-11-08</a></li></ul></div></div><div class="widget-categories widget"><h4 class=widget__title>Categories</h4><div class=widget__content><ul class=widget__list><li class=widget__item><a class=widget__link href=../../../categories/dailyreport/>DailyReport</a></li><li class=widget__item><a class=widget__link href=../../../categories/learnr/>LearnR</a></li></ul></div></div><div class="widget-taglist widget"><h4 class=widget__title>Tags</h4><div class=widget__content><a class="widget-taglist__link widget__link btn" href=../../../tags/daily/ title=Daily>Daily (14)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/research/ title=Research>Research (14)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week452025/ title=Week452025>Week452025 (7)</a></div><a href=../../../tags/></a></div><div class="widget-social widget"><h4 class="widget-social__title widget__title">Social</h4><div class="widget-social__content widget__content"><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Facebook rel="noopener noreferrer" href=https://facebook.com/username target=_blank><svg class="widget-social__link-icon icon icon-facebook" width="24" height="24" viewBox="0 0 352 352"><path d="m0 32v288c0 17.5 14.5 32 32 32h288c17.5.0 32-14.5 32-32V32c0-17.5-14.5-32-32-32H32C14.5.0.0 14.5.0 32zm320 0v288h-83V212h41.5l6-48H237v-31c0-14 3.5-23.5 23.5-23.5h26V66c-4.4-.6-19.8-1.5-37.5-1.5-36.9.0-62 22.2-62 63.5v36h-42v48h42v108H32V32z"/></svg>
<span>Facebook</span></a></div><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Twitter rel="noopener noreferrer" href=https://twitter.com/username target=_blank><svg class="widget-social__link-icon icon icon-twitter" width="24" height="24" viewBox="0 0 384 312"><path d="m384 36.9c-14.1 6.3-29.3 10.5-45.2 12.4 16.3-9.7 28.8-25.2 34.6-43.6-15.2 9-32.1 15.6-50 19.1-14.4-15.2-34.9-24.8-57.5-24.8-43.5.0-78.8 35.3-78.8 78.8.0 6.2.7 12.2 2 17.9-65.5-3.3-123.5-34.6-162.4-82.3C20 26 16.1 39.6 16.1 54c0 27.3 13.9 51.4 35 65.6-12.9-.4-25.1-4-35.7-9.9v1c0 38.2 27.2 70 63.2 77.2-6.6 1.8-13.6 2.8-20.8 2.8-5.1.0-10-.5-14.8-1.4 10 31.3 39.1 54.1 73.6 54.7-27 21.1-60.9 33.7-97.8 33.7-6.4.0-12.6-.4-18.8-1.1C34.9 299 76.3 312 120.8 312c144.9.0 224.1-120 224.1-224.1.0-3.4-.1-6.8-.2-10.2 15.4-11.1 28.7-25 39.3-40.8z"/></svg>
<span>Twitter</span></a></div><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Instagram rel="noopener noreferrer" href=https://www.instagram.com/username target=_blank><svg class="widget-social__link-icon icon icon-instagram" width="24" height="24" viewBox="0 0 256 256"><circle cx="193" cy="59" r="15"/><path fill-rule="evenodd" d="M101 0h54c41 0 58.4 3.9 74.5 17C256.2 37.5 256 74.8 256 97.7v60c0 26.7.0 60.4-26.5 81.4-16 13.4-33.5 16.9-74.5 16.9h-54c-41 0-57.5-3.5-74.5-16.9C1 218.9.5 186.3.1 160.5L0 155V97.7c0-23-.2-60.2 26.5-80.7C45 2 60 0 101 0zm4.9 23h44.3c45.8.0 58.3 3.5 70.3 17.5 11.8 13.2 12 30.1 12.5 62.9V156c.2 20.8.3 45.8-12.5 59.5-12 14-24.5 17.5-70.3 17.5h-44.3c-45.9.0-57.3-3.5-70.4-17.5-12.2-13-12.3-36.5-12.4-56.7v-55.6c.4-32.6.7-49.6 12.4-62.7C48 26.5 60 23 105.9 23zm19.6 144.5a42 42 0 100-84 42 42 0 000 84zm0 22.5a64.5 64.5.0 100-129 64.5 64.5.0 000 129z"/></svg>
<span>Instagram</span></a></div></div></div></aside></div><footer class=footer><div class="container footer__container flex"><div class=footer__copyright>&copy; 2025 ç”Ÿä¿¡æ™®æ‹‰æ–¯.
<span class=footer__copyright-credits>Generated with <a href=https://gohugo.io/ rel="nofollow noopener" target=_blank>Hugo</a> and <a href=https://github.com/Vimux/Mainroad/ rel="nofollow noopener" target=_blank>Mainroad</a> theme.</span></div></div></footer></div><script async defer src=../../../js/menu.js></script><script src=../../../js/custom.js></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.6/MathJax.js?config=TeX-AMS-MML_HTMLorMML" async></script></body></html>